Related Experiment Video

Updated: May 6, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

90.5K

Neurodevelopmental challenges at age four following fetal exposure to maternal opioid maintenance treatment

Minna M Kanervo1,2, Sarimari J Tupola3, Eeva M Nikkola3

  • 1University of Helsinki Doctoral School, Helsinki, Finland. minna.kanervo@hus.fi.

Pediatric Research
|March 28, 2025
PubMed

Insights

Children prenatally exposed to opioid maintenance treatment (OMT) face significantly higher risks of developmental and behavioral challenges. Early support and monitoring are crucial for these children with multiple risk factors.

Area of Science:

  • Neurodevelopmental studies
  • Child psychology
  • Public health research

Background:

  • The effects of intrauterine exposure to maternal opioid use disorder (OUD) and opioid maintenance treatment (OMT) on child development require further investigation.
  • This study examines neurodevelopmental and behavioral outcomes in four-year-old children with prenatal OMT exposure in Finland.

Purpose of the Study:

  • To investigate the neurodevelopmental and behavioral outcomes of children exposed to maternal OMT in utero.
  • To compare these outcomes with typically developing peers and national data.

Main Methods:

  • A population-based cohort study comparing 123 children exposed to buprenorphine±naloxone or methadone with 434 typically developing children.
  • Utilized standardized screening tests for language, motor-perceptual, and attention-behavioral skills.
  • Compared ICD-10 diagnoses with national data from 50,457 Finnish children.

Main Results:

  • Children with prenatal OMT exposure showed significantly higher rates of developmental challenges, including speech/language disorders, ADHD, and emotional/social disorders (ORs 8.97–210.21).
  • Additional risk factors identified include male sex, methadone exposure, illicit drug exposure, and domestic violence.
  • Significant associations were found between OMT exposure and various neurodevelopmental and behavioral disorders.

Conclusions:

  • Children born to mothers with OUD and OMT are at high risk for neurodevelopmental, emotional, and behavioral difficulties.
  • Early interventions, stable environments, and close monitoring are essential for this vulnerable population.
  • Additional risk factors like substance exposure and postnatal instability exacerbate these challenges, underscoring the need for comprehensive follow-up.
Abstract

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development15:27

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

14.3K
The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

9.3K

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K